High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy-Reference-Cited by-同舟云学术

High-grade Primary Central Nervous System Lymphomatoid Granulomatosis: Successful Rituximab Monotherapy

Published:2021-12-01 Issue:23 Volume:60 Page:3795-3799
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Harada Sakiko¹,Ando Jun¹,Ando Miki¹,Nitta Hideaki¹,Inano Tadaaki¹,Hirasawa Yusuke²,Furukawa Yoshiki¹,Kinoshita Shintaro¹,Kondo Akihide³,Ohshima Koichi⁴,Komatsu Norio¹

Affiliation:

1. Department of Hematology, Juntendo University School of Medicine, Japan

2. Department of Dermatology, Juntendo University School of Medicine, Japan

3. Department of Neurosurgery, Juntendo University School of Medicine, Japan

4. Department of Pathology, School of Medicine, Kurume University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/23/60_7232-21/_pdf

Reference17 articles.

1. 1. Pittaluga SWW, Jaffe ES. Lymphomatoid granulomatosis. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC, Lyon, 2017: 312.

2. 2. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 3: 457-558, 1972.

3. 3. Melani C, Jaffe ES, Wilson WH. Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder. Blood 135: 1344-1352, 2020.

4. 4. Song JY, Pittaluga S, Dunleavy K, et al. Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations. Am J Surg Pathol 39: 141-156, 2015.

5. 5. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 43: 360-373, 1979.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rituximab Monotherapy for Grade 2-3 Lymphomatoid Granulomatosis with Central Nervous System Involvement in a Patient Receiving Methotrexate for Rheumatoid Arthritis;Internal Medicine;2023

2. Immunosuppressants;Reactions Weekly;2022-04